CoChat

Effects of Leucine Administration in Sarcopenia: A Randomized and Placebo-controlled Clinical Trial

Open access
Martínez-Arnau, Francisco M., Fonfría-Vivas, Rosa, Buigues, Cristina, Castillo, Yolanda, Molina, Pilar, Hoogland, Aldert J., van Doesburg, Femke, Pruimboom, Leo, Fernández-Garrido, Julio, Cauli, Omar · 2020 · Nutrients

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

Treating sarcopenia in older individuals remains a challenge, and nutritional interventions present promising approaches in individuals that perform limited physical exercise. We assessed the efficacy of leucine administration to evaluate whether the regular intake of this essential amino acid can improve muscle mass, muscle strength and functional performance and respiratory muscle function in institutionalized older individuals. The study was a placebo-controlled, randomized, double-blind design in fifty participants aged 65 and over (ClinicalTrials.gov identifier NCT03831399). The participants were randomized to a parallel group intervention of 13 weeks’ duration with a daily intake of leucine (6 g/day) or placebo (lactose, 6 g/day). The primary outcome was to study the effect on sarcopenia and respiratory muscle function. The secondary outcomes were changes in the geriatric evaluation scales, such as cognitive function, functional impairment and nutritional assessments. We also evaluated whether leucine administration alters blood analytical parameters and inflammatory markers. Administration of leucine was well-tolerated and significantly improves some criteria of sarcopenia in elderly individuals such as functional performance measured by walking time (p = 0.011), and improved lean mass index. For respiratory muscle function, the leucine-treated group improved significantly (p = 0.026) in maximum static expiratory force compared to the placebo. No significant effects on functional impairment, cognitive function or nutritional assessment, inflammatory cytokines IL-6, TNF-alpha were observed after leucine administration compared to the placebo. The use of l-leucine supplementation can have some beneficial effects on sarcopenia and could be considered for the treatment of sarcopenia in older individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu12040932

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study flowchart.
Figure 1 Study flowchart.CC BY · PubMed Central
Figure 2 Effect of Leucine administration on sarcopenia criteria (A) and muscle respiratory sarcopenia (B). (A) Comparison of percentage changes compared to baseline values after leucine or placebo treatment for muscle mass index, handgrip strength and walking time * p = 0.011. (B) Comparison of percentage changes compared to baseline values after leucine or placebo treatment for respiratory muscle function * p = 0.026. Leucine group (LG); placebo group (PG); maximum static inspiratory (MIP) and expiratory (MEP) respiratory pressures at the mouth; peak expiratory flow (PEF).
Figure 2 Effect of Leucine administration on sarcopenia criteria (A) and muscle respiratory sarcopenia (B). (A) Comparison of percentage changes compared to baseline values after leucine or placebo treatment for muscle mass index, handgrip strength and walking time * p = 0.011. (B) Comparison of percentage changes compared to baseline values after leucine or placebo treatment for respiratory muscle function * p = 0.026. Leucine group (LG); placebo group (PG); maximum static inspiratory (MIP) and expiratory (MEP) respiratory pressures at the mouth; peak expiratory flow (PEF).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Bonnefoy, 2019, Quels bénéfices attendre de la supplémentation en protéines pour limiter la perte de masse et de fonction musculaire chez le sujet âgé fragile?, Geriatr. Psychol. Neuropsychiatr. Vieil., 17, 137

Cited by

See all 125

Metadata

Authors
Martínez-Arnau, F. M., Fonfría-Vivas, R., Buigues, C., Castillo, Y., Molina, P., Hoogland, A. J., van Doesburg, F., Pruimboom, L., Fernández-Garrido, J., & Cauli, O.
Affiliations
  • Department of Physiotherapy, University of Valencia, 46010 Valencia, Spain
  • Universitat de València (ES)
  • La Saleta, Armonea Group, 46015 Valencia, Spain
  • Natura Foundation, 3281 NC Numansdorp, The Netherlands
  • University Medical Center Groningen (NL)
  • Frailty and Cognitive Impairment Research Group (FROG), University of Valencia, 46010 Valencia, Spain
Corresponding author
Cauli, Omar
Venue
Nutrients
Publisher
MDPI AG
Published
2020-03-27
Volume
12
Issue
4
Pages
932
ISSN
2072-6643 (ISSN-L)
OpenAlex
W3013013531
Cited by
120
References
65
Citations by year
2026: 18 · 2025: 26 · 2024: 14 · 2023: 16 · 2022: 29 · 2021: 12 · 2020: 3
FWCI
9.02
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Funders
Universitat de València
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
sarcopenia, leucine supplementation, older adults, muscle mass, muscle strength, functional performance, respiratory muscle function, lean mass index, dietary intervention, institutionalized elderly, cognitive function, inflammatory cytokines
MeSH terms
Aged, Aged, 80 and over, Double-Blind Method, Female, Humans, Leucine, Male, Respiratory Muscles, Muscle Strength, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.